CU20170164A7 - Compuestos n-tieno (2,3-d)pirimidinil-d-fenilalanina, método para preparar los mismos y composiciones farmacéuticas que los contienen - Google Patents

Compuestos n-tieno (2,3-d)pirimidinil-d-fenilalanina, método para preparar los mismos y composiciones farmacéuticas que los contienen

Info

Publication number
CU20170164A7
CU20170164A7 CUP2017000164A CU20170164A CU20170164A7 CU 20170164 A7 CU20170164 A7 CU 20170164A7 CU P2017000164 A CUP2017000164 A CU P2017000164A CU 20170164 A CU20170164 A CU 20170164A CU 20170164 A7 CU20170164 A7 CU 20170164A7
Authority
CU
Cuba
Prior art keywords
pyrimidinyl
preparing
pharmaceutical compositions
compositions containing
tien
Prior art date
Application number
CUP2017000164A
Other languages
English (en)
Spanish (es)
Inventor
Balázs Bálint
Alain Bruno
I- Jen Chen
Márton Csékei
James Edward Paul Davidson
Radics GÁBOR
Olivier Geneste
András Kotschy
James Brooke Murray
Levente Ondi
Attila Paczal
Françoise Perron-Sierra
Ágnes Proszenyák
Szabolcs Sipos
Zoltán Szabó
Zoltán Szlávik
Original Assignee
Servier Lab
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Vernalis R&D Ltd filed Critical Servier Lab
Publication of CU20170164A7 publication Critical patent/CU20170164A7/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CUP2017000164A 2015-06-23 2016-06-22 Compuestos n-tieno (2,3-d)pirimidinil-d-fenilalanina, método para preparar los mismos y composiciones farmacéuticas que los contienen CU20170164A7 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1555747A FR3037956B1 (fr) 2015-06-23 2015-06-23 Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/EP2016/064436 WO2016207226A1 (en) 2015-06-23 2016-06-22 New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
CU20170164A7 true CU20170164A7 (es) 2018-05-08

Family

ID=54260901

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2017000164A CU20170164A7 (es) 2015-06-23 2016-06-22 Compuestos n-tieno (2,3-d)pirimidinil-d-fenilalanina, método para preparar los mismos y composiciones farmacéuticas que los contienen

Country Status (43)

Country Link
US (1) US10457687B2 (lt)
EP (1) EP3313850B1 (lt)
JP (1) JP6741698B2 (lt)
KR (1) KR102620905B1 (lt)
CN (1) CN107709334B (lt)
AR (1) AR105101A1 (lt)
AU (1) AU2016282837B2 (lt)
CA (1) CA2990089C (lt)
CL (1) CL2017003163A1 (lt)
CO (1) CO2017012830A2 (lt)
CR (2) CR20170590A (lt)
CU (1) CU20170164A7 (lt)
CY (1) CY1120991T1 (lt)
DK (1) DK3313850T3 (lt)
EA (1) EA034587B1 (lt)
EC (1) ECSP17082546A (lt)
ES (1) ES2703997T3 (lt)
FR (1) FR3037956B1 (lt)
GE (1) GEP20207075B (lt)
HK (2) HK1250234A1 (lt)
HR (1) HRP20181806T1 (lt)
IL (1) IL256191B (lt)
JO (1) JO3430B1 (lt)
LT (1) LT3313850T (lt)
MA (1) MA42232B1 (lt)
MD (1) MD3313850T2 (lt)
MX (1) MX368845B (lt)
MY (1) MY189472A (lt)
NZ (1) NZ738459A (lt)
PE (1) PE20190111A1 (lt)
PH (1) PH12017502266A1 (lt)
PL (1) PL3313850T3 (lt)
PT (1) PT3313850T (lt)
RS (1) RS57961B1 (lt)
RU (1) RU2747673C2 (lt)
SA (1) SA517390583B1 (lt)
SI (1) SI3313850T1 (lt)
SV (1) SV2017005588A (lt)
TN (1) TN2017000521A1 (lt)
TW (1) TWI631124B (lt)
UA (1) UA123267C2 (lt)
UY (1) UY36733A (lt)
WO (1) WO2016207226A1 (lt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3037957B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037959B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037958B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TWI759316B (zh) 2016-07-22 2022-04-01 法商施維雅藥廠 Bcl-2抑制劑及mcl1抑制劑之組合、其用途及醫藥組合物
EP3565547B1 (en) * 2017-01-06 2024-03-13 Les Laboratoires Servier Combination of a mcl-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereof
UY37560A (es) 2017-01-06 2018-07-31 Servier Lab Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta
UA126920C2 (uk) 2017-06-22 2023-02-22 Ле Лаборатуар Сервьє Комбінація інгібітору mcl-1 і стандартного лікарського препарату для лікування гематологічних злоякісних новоутворень, її застосування та фармацевтичні композиції, що її містять
US20200255451A1 (en) * 2017-08-15 2020-08-13 Abbvie Inc. Macrocyclic mcl-1 inhibitors and methods of use
CN111818917A (zh) 2017-08-15 2020-10-23 艾伯维公司 大环mcl-1抑制剂和使用方法
CN110964034B (zh) * 2018-09-29 2022-04-12 江苏恒瑞医药股份有限公司 嘧啶并噻吩类衍生物、其制备方法及其在医药上的应用
AR116635A1 (es) 2018-10-15 2021-05-26 Servier Lab Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen
TWI849001B (zh) 2018-11-14 2024-07-21 法商施維雅藥廠 Mcl-1抑制劑及米哚妥林(midostaurin)之組合，其用途及醫藥組合物
CN111187277B (zh) * 2018-11-14 2022-04-12 江苏恒瑞医药股份有限公司 噻吩并嘧啶类衍生物、其制备方法及其在医药上的应用
KR20220017931A (ko) 2019-05-20 2022-02-14 노파르티스 아게 Mcl-1 억제제 항체-약물 접합체 및 사용 방법
WO2020254299A1 (en) 2019-06-17 2020-12-24 Les Laboratoires Servier Combination of a mcl-1 inhibitor and a standard of care treatment for breast cancer, uses and pharmaceutical compositions thereof
CN112457308B (zh) 2019-09-09 2024-01-02 上海长森药业有限公司 新型三环芳香杂环化合物，及其制备方法、药物组合物和应用
WO2022115451A1 (en) 2020-11-24 2022-06-02 Novartis Ag Mcl-1 inhibitor antibody-drug conjugates and methods of use
TW202317200A (zh) 2021-06-11 2023-05-01 美商基利科學股份有限公司 Ｍｃｌ－１抑制劑與抗體藥物接合物之組合
TW202315637A (zh) 2021-06-11 2023-04-16 美商基利科學股份有限公司 Mcl-1抑制劑與抗癌劑之組合
TW202408588A (zh) 2022-05-20 2024-03-01 瑞士商諾華公司 抗體-藥物結合物抗腫瘤化合物及其使用方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL96531A (en) * 1989-12-11 1995-08-31 Univ Princeton History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
DE10058663A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Thienopyrimidinen
US20070213305A1 (en) * 2005-11-02 2007-09-13 Cytovia, Inc. N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP2276346B1 (en) * 2008-04-30 2016-11-23 National Health Research Institutes Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
WO2012044993A1 (en) * 2010-09-30 2012-04-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
CN102464667B (zh) * 2010-11-03 2014-06-04 中国科学院上海药物研究所 一类五元杂环并嘧啶类化合物及其制备方法和用途
UA109916C2 (uk) * 2010-12-20 2015-10-26 Гленмарк Фармасьютікалс С.А. 2-аміно-4-арилтіазольні сполуки як антагоністи trра1
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
FR2986002B1 (fr) * 2012-01-24 2014-02-21 Servier Lab Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20150307532A1 (en) 2012-11-20 2015-10-29 The Royal Institution For The Advancement Of Learning/Mcgill University Thienopyrimidine inhibitors of farnesyl and/or geranylgeranyl pyrophosphate synthase
FR3015483B1 (fr) * 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037957B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037959B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037958B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3046792B1 (fr) * 2016-01-19 2018-02-02 Les Laboratoires Servier Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
EA034587B1 (ru) 2020-02-25
CL2017003163A1 (es) 2018-06-15
EA201890123A1 (ru) 2018-05-31
BR112017027645A2 (pt) 2018-08-28
PH12017502266B1 (en) 2018-06-11
IL256191A (en) 2018-02-28
MX368845B (es) 2019-10-18
AR105101A1 (es) 2017-09-06
EP3313850B1 (en) 2018-10-03
PE20190111A1 (es) 2019-01-15
DK3313850T3 (en) 2019-01-28
NZ738459A (en) 2024-05-31
MX2017016996A (es) 2018-08-23
HK1252113A1 (zh) 2019-05-17
IL256191B (en) 2020-03-31
EP3313850A1 (en) 2018-05-02
LT3313850T (lt) 2018-11-26
TN2017000521A1 (en) 2019-04-12
HRP20181806T1 (hr) 2018-12-28
CN107709334A (zh) 2018-02-16
WO2016207226A1 (en) 2016-12-29
SV2017005588A (es) 2018-06-01
PL3313850T3 (pl) 2019-04-30
RU2018102372A (ru) 2019-07-23
FR3037956B1 (fr) 2017-08-04
SI3313850T1 (sl) 2019-01-31
KR20180015261A (ko) 2018-02-12
JP2018522856A (ja) 2018-08-16
ES2703997T3 (es) 2019-03-13
CN107709334B (zh) 2021-04-13
RU2747673C2 (ru) 2021-05-12
CA2990089A1 (en) 2016-12-29
CR20170571A (es) 2018-02-20
US20190031675A1 (en) 2019-01-31
HK1252113B (zh) 2020-01-10
CR20170590A (es) 2018-02-26
AU2016282837A1 (en) 2018-01-18
FR3037956A1 (lt) 2016-12-30
CA2990089C (en) 2020-11-03
ECSP17082546A (es) 2018-02-28
JP6741698B2 (ja) 2020-08-19
MA42232A (fr) 2016-12-29
TWI631124B (zh) 2018-08-01
HK1250234A1 (zh) 2018-12-07
JO3430B1 (ar) 2019-10-20
PT3313850T (pt) 2018-11-29
MY189472A (en) 2022-02-16
MD3313850T2 (ro) 2019-02-28
UY36733A (es) 2016-12-30
CO2017012830A2 (es) 2018-03-28
RU2018102372A3 (lt) 2019-11-06
PH12017502266A1 (en) 2018-06-11
RS57961B1 (sr) 2019-01-31
CY1120991T1 (el) 2019-12-11
GEP20207075B (en) 2020-03-10
AU2016282837B2 (en) 2020-05-28
MA42232B1 (fr) 2018-11-30
TW201712018A (zh) 2017-04-01
SA517390583B1 (ar) 2022-02-20
US10457687B2 (en) 2019-10-29
UA123267C2 (uk) 2021-03-10
KR102620905B1 (ko) 2024-01-04

Similar Documents

Publication Publication Date Title
CU20170164A7 (es) Compuestos n-tieno (2,3-d)pirimidinil-d-fenilalanina, método para preparar los mismos y composiciones farmacéuticas que los contienen
SV2017005514A (es) Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos
CU24466B1 (es) Compuestos derivados de d-fenilalanina-n-sustituido con biciclos aromáticos, método de preparación de las mismas y composiciones farmacéuticas que los contienen
SV2018005794A (es) Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos
SV2017005587A (es) Nuevos derivados hidroxiester, un proceso para su preparacion y composiciones farmaceutacas que los contienen
CU24309B1 (es) Compuestos derivados tienopirimidina y composiciones farmacéuticas que los contienen
SV2018005791A (es) Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
CU20180146A7 (es) Compuestos derivados de (piperidin-1-ilo)(piperidin-4-ilo) sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que los contienen
CU20180073A7 (es) Nuevos derivados de amonio, un proceso para su preparación y composiciones farmacéuticas que los contienen
CR20170118A (es) Derivados espirodiamina como inhibidores de la aldosterona sintasa
CL2017002452A1 (es) Nuevos compuestos bicíclicos
CU20170162A7 (es) Derivados de fenil-tieno(2,3-d)pirimidina-hidroxiácido útiles en el tratamiento del cáncer y enfermedades autoinmunes, método de preparación de los mismos y composiciones farmacéuticas que los contienen
DOP2017000202A (es) Desacetoxitubulisina h y análogos de esta
ECSP14013264A (es) Nuevos derivados bicíclicos de dihidroquinolina-2-ona
ECSP17069696A (es) Compuestos novedosos
CU20180028A7 (es) DERIVADOS DE IMIDAZO[4,5-b]PIRIDINA, ÚTILES COMO INHIBIDORES DUALES DE DYRK1/CLK1 Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN
UY35664A (es) Nuevos compuestos isoindolina o isoquinolina, un proceso para su preparación y composiciones farmacéuticas que los contienen
SV2014004879A (es) Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen